CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), today announced that the Company’s Chief Science Officer, Edward Wirth III, MD, PhD will be presenting at the Interdependence 2012 show currently being held in Vancouver through May 17th, 2012.
